...
首页> 外文期刊>Journal of cell biology >1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
【24h】

1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.

机译:1,25-二羟基维生素D3诱导的人类早幼粒细胞白血病细胞系(HL-60)的分化:受体介导的巨噬细胞样细胞成熟。

获取原文
           

摘要

The human-derived promyelocytic leukemia cell line, HL-60, is known to differentiate into mature myeloid cells in the presence of 1,25-dihydroxyvitamin D3 (1,25[OH]2D3). We investigated differentiation by monitoring 1,25(OH)2D3-exposed HL-60 cells for phagocytic activity, ability to reduce nitroblue tetrazolium, binding of the chemotaxin N-formyl-methionyl-leucyl-[3H]phenylalanine, development of nonspecific acid esterase activity, and morphological maturation of Wright-Giemsa-stained cells. 1,25(OH)2D3 concentrations as low as 10(-10) M caused significant development of phagocytosis, nitroblue tetrazolium reduction, and the emergence of differentiated myeloid cells that had morphological characteristics of both metamyelocytes and monocytes. These cells were conclusively identified as monocytes/macrophages based upon their adherence to the plastic flasks and their content of the macrophage-characteristic nonspecific acid esterase enzyme. The estimated ED50 for 1,25(OH)2D3-induced differentiation based upon nitroblue tetrazolium reduction and N-formyl-methionyl-leucyl-[3H]phenylalanine binding was 5.7 X 10(-9) M. HL-60 cells exhibited a complex growth response with various levels of 1,25(OH)2D3: less than or equal to 10(-10) M had no detectable effect, 10(-9) M stimulated growth, and greater than or equal to 10(-8) M sharply inhibited proliferation. We also detected and quantitated the specific receptor for 1,25(OH)2D3 in HL-60 and HL-60 Blast, a sub-clone resistant to the growth and differentiation effects of 1,25(OH)2D3. The receptor in both lines was characterized as a DNA-binding protein that migrated at 3.3S on high-salt sucrose gradients. Unequivocal identification was provided by selective dissociation of the 1,25(OH)2D3-receptor complex with the mercurial reagent, p-chloromercuribenzenesulfonic acid, and by a shift in its sedimentation position upon complexing with anti-receptor monoclonal antibody. On the basis of labeling of whole cells with 1,25(OH)2[3H]D3 in culture, we found that HL-60 contains approximately 4,000 1,25(OH)2D3 receptor molecules per cell, while the nonresponsive HL-60 Blast is endowed with approximately 8% of that number. The concentration of 1,25(OH)2D3 (5 X 10(-9) M) in complete culture medium, which facilitates the saturation of receptors in HL-60 cells, is virtually identical to the ED50 for the sterol's induction of differentiation. This correspondence, plus the resistance of the relatively receptor-poor HL-60 Blast, indicates that 1,25(OH)2D3-induced differentiation of HL-60 cells to monocytes/macrophages is occurring via receptor-mediated events.
机译:已知人类衍生的早幼粒细胞白血病细胞系HL-60在1,25-二羟基维生素D3(1,25 [OH] 2D3)存在下可分化为成熟的髓样细胞。我们通过监测暴露于1,25(OH)2D3的HL-60细胞的吞噬活性,还原硝基蓝四唑的能力,化学趋化因子N-甲酰基-甲硫酰基-亮氨酰-[3H]苯丙氨酸的结合,非特异性酸酯酶的发展来研究分化Wright-Giemsa染色细胞的活性和形态成熟。低至10(-10)M的1,25(OH)2D3浓度引起吞噬作用的显着发展,硝基蓝四唑还原和分化的髓样细胞的出现,这些髓样细胞具有干髓细胞和单核细胞的形态特征。根据它们对塑料瓶的粘附性以及它们具有巨噬细胞特征的非特异性酸酯酶的含量,将这些细胞最终鉴定为单核细胞/巨噬细胞。基于硝基蓝四唑还原和N-甲酰基-甲硫酰基-亮氨酰-[3H]苯丙氨酸结合的1,25(OH)2D3诱导的分化的估计ED50为5.7 X 10(-9)M。HL-60细胞表现出复杂不同水平的1,25(OH)2D3的生长响应:小于或等于10(-10)M没有可检测的作用,10(-9)M刺激的生长,大于或等于10(-8) M急剧抑制增殖。我们还检测并定量了HL-60和HL-60 Blast中对1,25(OH)2D3的特异性受体,该亚克隆对1,25(OH)2D3的生长和分化作用具有抗性。两条细胞系中的受体都被表征为DNA结合蛋白,该蛋白在高盐蔗糖梯度下以3.3S迁移。通过将1,25(OH)2D3-受体复合物与水银试剂对氯汞苯磺酸选择性解离,以及与抗受体单克隆抗体复合后沉淀位置的变化,可以明确鉴定。根据在培养物中用1,25(OH)2 [3H] D3标记整个细胞的基础,我们发现HL-60每个细胞大约包含4,000个1,25(OH)2D3受体分子,而无反应的HL-60冲击波被赋予该数字的8%。完全培养基中1,25(OH)2D3(5 X 10(-9)M)的浓度可促进HL-60细胞中受体的饱和,实际上与用于诱导甾醇分化的ED50相同。这种对应关系,加上相对较差的HL-60 Blast的抗性,表明通过受体介导的事件发生了1,25(OH)2D3诱导的HL-60细胞向单核细胞/巨噬细胞的分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号